MAPT and Alzheimer disease: Given that tau accumulation, not Aβ burden, is more closely connected with cognitive change in the AD continuum [13–15], a detailed understanding of the relationship between tau accumulation and specific cognitive function is critical for effectively capturing AD-related symptoms at the earliest stage of the disease.